Catalytic [4+2]- and [4+4]-cycloaddition using furan-fused cyclobutanone as a privileged C4 synthon

Kemiao Hong,Mengting Liu,Lixin Qian,Ming Bao,Gang Chen,Xinyu Jiang,Jingjing Huang,Xinfang Xu
DOI: https://doi.org/10.1038/s41467-024-49664-5
IF: 16.6
2024-06-27
Nature Communications
Abstract:Cycloaddition reactions play a pivotal role in synthetic chemistry for the direct assembly of cyclic architectures. However, hurdles remain for extending the C4 synthon to construct diverse heterocycles via programmable [4+n]-cycloaddition. Here we report an atom-economic and modular intermolecular cycloaddition using furan-fused cyclobutanones (FCBs) as a versatile C4 synthon. In contrast to the well-documented cycloaddition of benzocyclobutenones, this is a complementary version using FCB as a C4 reagent. It involves a C-C bond activation and cycloaddition sequence, including a Rh-catalyzed enantioselective [4 + 2]-cycloaddition with imines and an Au-catalyzed diastereoselective [4 + 4]-cycloaddition with anthranils. The obtained furan-fused lactams, which are pivotal motifs that present in many natural products, bioactive molecules, and materials, are inaccessible or difficult to prepare by other methods. Preliminary antitumor activity study indicates that 6e and 6 f exhibit high anticancer potency against colon cancer cells (HCT-116, IC 50 = 0.50 ± 0.05 μM) and esophageal squamous cell carcinoma cells (KYSE-520, IC 50 = 0.89 ± 0.13 μM), respectively.
multidisciplinary sciences
What problem does this paper attempt to address?
The main problem that this paper attempts to solve is how to achieve efficient and modular intermolecular cycloaddition reactions by using furan - fused cyclobutanones (FCBs) as C4 synthons to construct heterocyclic compounds with structural diversity. Specifically: 1. **Expand the application of C4 synthons**: Traditional C4 synthons have limitations in constructing diverse heterocyclic structures, especially in constructing heterocycles through programmable [4 + n] cycloaddition reactions. This paper proposes a novel, atom - economic and modular method, using FCBs as C4 synthons, to solve this problem. 2. **Achieve highly selective cycloaddition reactions**: - Through Rh - catalyzed enantioselective [4 + 2] cycloaddition reactions with imines. - Through Au - catalyzed diastereoselective [4 + 4] cycloaddition reactions with anthranils. 3. **Prepare bioactive compounds**: The obtained furan - fused lactams are key structural units in many natural products, bioactive molecules and materials, and these compounds are difficult to synthesize by other methods. Preliminary anti - tumor activity studies show that some compounds (such as 6e and 6f) exhibit significant anti - cancer activity against colon cancer cells (HCT - 116) and esophageal squamous cell carcinoma cells (KYSE - 520) (IC50 are 0.50 ± 0.05 μM and 0.89 ± 0.13 μM respectively). 4. **Improve synthesis efficiency and diversity**: Through this cycloaddition strategy, complex multi - substituted furan derivatives can be rapidly constructed, and these products can be further derivatized into a variety of heterocyclic compounds with structural diversity through conventional operations, showing its great potential in medicinal chemistry and new material development. In summary, this research aims to develop a new catalytic system that can efficiently use FCBs as C4 synthons for modular intermolecular cycloaddition reactions, thereby achieving the synthesis of heterocyclic compounds with complex structures and potential medicinal values.